Furthermore, two independent studies identically discover that plasma circ-LDLRAD3 overexpression significantly correlates with pancreatic cancer, in which together with CA19-9, combinative test has 80.3% sensitivity and 93.6% specificity in early diagnosis of pancreatic cancer (267, 268). The gene discussed is LDLRAD3; the disease is pancreatic neoplasm.